India's Ambassador to Kazakhstan Sailas Thangal presented Zhumagali Ismailov, Professor and Doctor of Medical Sciences, with an award for his outstanding contribution to the development of the Indian community in Kazakhstan, Qazinform News Agency reports. The award ceremony was held to mark the 80th anniversary of India's independence.
Over the past six years, Indian specialists have contributed to the development of medical education and healthcare in Kazakhstan, including through a public-private partnership aimed at modernizing the Almaty Multidisciplinary Clinical Hospital (AMCH). Under the partnership, IAMS, the hospital's private management partner headed by Ismailov, has overseen its modernization, introducing advanced technologies, upgrading facilities and equipment, and strengthening its workforce.
These efforts have expanded the number of high-tech medical services offered at the hospital from just two to 31, making it one of Kazakhstan's leading medical facilities in this area. The next stage of the partnership will see the construction of a new medical complex, with the private partner set to invest around 11 billion tenge in the facility, its infrastructure, and modern medical equipment.
According to Ismailov, the project will focus on improving healthcare through investment in skilled professionals and modern technologies, enabling residents to access high-quality medical care without having to travel outside the region. India is widely recognized for its expertise in affordable healthcare, pharmaceuticals, and medical tourism, offering advanced medical technologies at relatively accessible costs.
Ismailov's award also highlights the growing healthcare partnership between Kazakhstan and India, which has expanded beyond the exchange of expertise to include investment, infrastructure development, and the introduction of modern medical technologies. According to the report, the key goal of these efforts is to improve access to quality healthcare for residents of the Almaty region.
Earlier, scientists in India developed a new “smart” cancer drug designed to target cancer cells while minimizing damage to healthy tissue.